Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer

Figure 2

Mean change in pre- and post-treatment data. (a) ER H-score, (b) PgR H-score and (c) Ki67 labeling index. Where the overall tests for treatment effect were not significant for total PgR H-score and Ki67 index, pairwise comparisons were deemed non-significant. Error bars represent standard error of the mean. ER, estrogen receptor; NS, not significant; PgR, progesterone receptor.

Back to article page